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Summary
Krüppel-like factor 5 (KLF5) is a zinc-finger transcription factor known to play a pivotal role in the pathogenesis of cardio-
vascular disease. Here, we show that neonatal heterozygous KLF5 knockout mice exhibit a marked deficiency in white
adipose tissue development, suggesting that KLF5 is also required for adipogenesis. In 3T3-L1 preadipocytes, KLF5 ex-
pression was induced at an early stage of differentiation, and this was followed by expression of PPARγ2. Constitutive
overexpression of dominant-negative KLF5 inhibited adipocyte differentiation, whereas overexpression of wild-type KLF5
induced differentiation even without hormonal stimulation. Moreover, embryonic fibroblasts obtained from KLF5+/− mice
showed much attenuated adipocyte differentiation, confirming the key role played by KLF5 in adipocyte differentiation.
KLF5 expression is induced by C/EBPβ and δ. KLF5, in turn, acts in concert with C/EBPβ/δ to activate the PPARγ2 promoter.
This study establishes KLF5 as a key component of the transcription factor network controlling adipocyte differentiation.Introduction
Adipose tissue plays an essential role in energy homeostasis
(Spiegelman and Flier, 1996). In mammals, for example, brown
adipose tissue (BAT) dissipates energy through thermogenesis,
while white adipose tissue (WAT) stores excess energy as tri-
glyceride and releases free fatty acids during periods of energy
starvation. Moreover, recent studies have established adipose
tissue as an active endocrine organ that secretes various hu-
moral factors called adipocytokines. Adipocytokines have been
shown to be involved in numerous physiological and pathologi-
cal functions, including food intake, energy metabolism, insulin
sensitivity, reproduction, inflammatory responses, atherogene-
sis, and angiogenesis (Flier, 2004). Thus, a better understand-
ing of the molecular mechanisms that control adipose tissue
development and function should improve our understanding
of the pathogenesis and pathophysiology of metabolic syn-
drome, diabetes mellitus, and cardiovascular disease.
Earlier studies identified a number of transcription factors in-
volved in adipocyte differentiation. These include peroxisome
proliferator-activated receptor γ (PPARγ) and members of the
C/EBP family of transcription factors (Morrison and Farmer,
2000; Rosen et al., 2000). In 3T3-L1 preadipocytes, a hormonal
adipogenic stimulus triggers a cascade of transcription factor
expression in which C/EBPδ and C/EBPβ are induced immedi-
ately, and expression of C/EBPα and PPARγ2 follows after a
certain time lag. PPARγ2 is expressed specifically in adipocytes
and has been shown to control a number of adipocyte-specific
genes, while C/EBPα is also required for expression of severalCELL METABOLISM : JANUARY 2005 · VOL. 1 · COPYRIGHT © 2005 ELadipose-specific genes. Consequently, these two transcription
factors are thought to be central to the control of adipocyte-
specific gene expression. Moreover, the sequential expression
of these transcription factors provides correlative evidence for
a model in which expression of PPARγ2 and C/EBPα are in-
duced by C/EBPβ and δ (Darlington et al., 1998; Rosen et al.,
2000). Once activated, PPARγ2 and C/EBPα appear to cross-
regulate one another and to maintain their expression in mature
3T3-L1 adipocytes, although C/EBPβ/δ is no longer expressed.
Thus, a basic framework for studying the adipocyte differentia-
tion program has been laid out. Nevertheless, critical aspects
of the transcriptional control of adipocyte differentiation remain
unclear. For instance, C/EBPα/β/δ are in fact not adipocyte-
specific and are known to be involved in the differentiation of
myeloid cells, hepatocytes, mammary epithelial cells, and ker-
atinocytes, among others (Ramji and Foka, 2002). C/EBPβ/δ
are also induced by inflammatory stimuli in a number of cell types
and control genes important for the inflammatory response. It is
thus unclear how a gene expression cascade initiated by
widely expressed C/EBPβ/δ induces an adipocyte-specific
gene program involving PPARγ and C/EBPα exclusively in pre-
adipocytes, especially since there is a rather long time lag
(w30 hr) between expression of C/EBPβ/δ and expression of
their target genes, PPARγ2 and C/EBPα (Tang and Lane, 1999).
Furthermore, although C/EBPβ/δ double knockout mice exhibit
a remarkably small mass of epididymal WAT, levels of PPARγ
and C/EBPα expression are similar to those in wild-type mice
(Tanaka et al., 1997), indicating that in some circumstances, at
least, C/EBPβ/δ are dispensable for induction of PPARγ andSEVIER INC. DOI:10.1016/j.cmet.2004.11.005 27
A R T I C L EFigure 1. Deficient WAT development in KLF5+/−
mice
A) Transverse sections at the level of the neck (a, b)
and scapula (c, d) were obtained from wild-type (a,
c) and KLF5+/− mice (b, d) three days after birth.
Although the mass of WAT was clearly smaller in
KLF5+/− (b) than in wild-type (a) mice, similar
amounts of BAT were found in both lines (c and d).
B) High magnification micrographs of WAT sections
from mice three days (upper panel) and four weeks
(lower panel) after birth. Note that many smaller
cells were present in KLF5+/− WAT three days after
birth. Scale bars are equal to 50 m.
C) Real-time PCR analysis of adipocyte marker
genes and transcription factors. Expression levels
of each gene were normalized to the levels of the
housekeeping gene 36B4. Error bars indicate S.D.
(n = 4); *p < 0.05, **p < 0.01 versus control; N.S., no
significant difference.
D) Immunoblot analysis of KLF5 protein in the epi-
didymal WAT from 4-week-old mice. Arrowheads in-
dicate the bands corresponding to KLF5.28 CELL METABOLISM : JANUARY 2005
KLF5 in adipogenesisC/EBPα, and that other factors are also involved in the tran-
scriptional control of adipocyte differentiation. Indeed, several
additional transcription factors have been shown to function in
adipogenesis, including Wnt, Foxo1, CREB, ADD1/SREBP-1c,
and KLF15 (Gray et al., 2002; MacDougald and Mandrup,
2002; Nakae et al., 2003).
Members of the Krüppel-like factor (KLF) family of transcrip-
tion factors are important regulators of development, cellular
differentiation and growth, and pathogenesis of atherosclerosis
and in tumor development (Kaczynski et al., 2003). Recent
studies also suggest a potential role for KLFs in adipogenesis.
KLF2, for instance, is expressed in 3T3-L1 preadipocytes but
is rapidly downregulated upon hormonal stimulation (Banerjee
et al., 2003). KLF2 binds directly to the PPARγ2 promoter and
inhibits its activity. On the other hand, KLF15 is induced late
during 3T3-L1 differentiation and positively regulates GLUT4
(Gray et al., 2002). Finally, KLF6 is reportedly induced by adipo-
genic hormonal stimulation in 3T3-L1 cells. The functions of
these KLFs in adipocyte differentiation in vivo remain un-
known, however.
KLF5 was identified as a positive regulator of SMemb, a
marker gene for activated smooth muscle cells in vascular dis-
ease (Watanabe et al., 1999). Recently, we generated a strain
of KLF5 knockout mice and were able to show that KLF5 medi-
ates cardiovascular remodeling in vivo (Shindo et al., 2002).
Although KLF5 homozygous knockout (KLF5−/−) mice die in
utero before ED8.5, the heterozygous knockout (KLF5+/−) mice
are apparently normal and fertile. In response to vascular injury,
however, KLF5+/− mice exhibit much less granulation and neo-
intima formation. Likewise, cardiac hypertrophy and fibrosis
are attenuated in KLF5+/− mice.
In the present study, we found that neonatal KLF5+/− mice
carried much less WAT mass than wild-type mice, suggesting
KLF5 also plays a role in WAT development in vivo. We there-
fore analyzed the molecular mechanism by which KLF5 controlsFigure 2. Expression of KLF5 during 3T3-L1 adipocyte differentiation
A) Expression of KLF5 and other adipogenic transcription factors during differen-
tiation of 3T3-L1 cells was analyzed using semiquantitative RT-PCR. Cells were
harvested at the indicated times. Arrowheads indicate positions of PCR bands
corresponding to the respective target genes; asterisks indicate bands for 18s
rRNA, which served as an internal control.
B) Western blot analysis of KLF5 protein during 3T3-L1 differentiation.CELL METABOLISM : JANUARY 2005WAT development and found that KLF5 is induced by C/EBPβ/δ,
and that it then acts in concert with C/EBPβ/δ to regulate
PPARγ2 expression, thereby mediating the activity of both the
early differentiation factors C/EBPβ/δ and a late factor, PPARγ2.
These results provide compelling evidence that KLF5 is a key
regulator of the transcription factor network that governs adi-
pocyte differentiation.
Results
WAT development is impaired in KLF5+/− mice
As reported previously (Shindo et al., 2002), KLF5+/− mice ap-
peared virtually indistinguishable from their wild-type litter-
mates. There was, however, a mild but significant difference in
body weight (wild-type, 1.44 g versus KLF5+/−, 1.31 g on day
3 after birth; n = 10 each, p < 0.05), and cross-sections of 3-day-
old neonates showed the WAT masses in the neck and back
to be markedly smaller in KLF5+/− mice than wild-type mice
(Figure 1A; Supplemental Table S1 and Supplemental Figure
S1 available with this article online). Despite this difference in
WAT mass, there was no difference in the number of adipo-
cytes in WAT seen in sections from corresponding areas of the
neck in the two groups. But in KLF5+/− WAT, there were a
number of small cells, some of which contained little or no lipid
(Figure 1B, upper panel), and adipocytes that did contain lipid
droplets were nonetheless significantly smaller in KLF5+/− sec-
tions (mean cell area: KLF5+/−, 275.4 ± 191.8 m2 versus wild-
type, 721.5 ± 316.3 m2; n = 3 each, p < 0.05). In contrast to
WAT, interscapular BAT masses were similar in the two groups
on day 3 after birth (Figure 1A, c versus d).
Although clearly reduced in neonates, by 4 weeks of age
WAT mass and morphology in KLF5+/− mice was comparable
to that in wild-type mice (Figure 1B, lower panel). Body weights
were also comparable in the two groups of adult mice. Given
that the characteristic morphology of adipocytes normally de-
velops in the first 24 hr after birth (Rosen, 2002), these results
suggest that haploinsufficiency of KLF5 results in delayed WAT
development. In that regard, the levels of expression of adipo-
cyte marker genes including adipocyte P2 (aP2) and phospho-
enolpyruvate carboxykinase (PEPCK) were significantly lower
in KLF5+/− WAT than wild-type WAT on day 3 after birth (Figure
1C), as was expression of C/EBPα and PPARγ. On the other
hand, expression of C/EBPβ and C/EBPδ, transcription factors
thought to be situated upstream of PPARγ2, was comparable
in the two groups. As expected, expression of KLF5 protein was
reduced in the WAT of 4-week-old KLF5+/− mice (Figure 1D).
KLF5 is induced in the early stages
of adipocyte differentiation
To determine the function of KLF5 in WAT development, we
first examined expression of KLF5 during adipocyte differentia-
tion. 3T3-L1 preadipocytes are a well-characterized in vitro
model of adipocyte differentiation that can differentiate into
mature adipocytes upon exposure to a mixture hormonal stim-
uli (Ntambi et al., 1988). During that process, expression of
KLF5 mRNA was increased beginning 1 hr after induction of
differentiation, following the immediate induction of C/EBPβ
and δ (Figure 2A and Supplemental Figure S2). KLF5 transcrip-
tion reached a maximum within 3 hr, after which the expression
gradually declined, though KLF5 mRNA remained detectable
for 120 hr. Induction of KLF5 was followed by expression of29
A R T I C L EFigure 3. KLF5 is necessary and sufficient for 3T3-L1 adipocyte differentiation
A) 3T3-L1 cells were infected with empty retroviral vector or vector harboring KLF5 or DN-KLF5. On day 8 after induction of differentiation, cells were stained with Oil-
Red-O.
B) RT-PCR analysis of expression of adipocyte-specific genes in cells infected with empty (e) or DN-KLF5-harboring (DN) retroviral vector. Cells were induced to
differentiate by hormonal stimulation.
C) 3T3-L1 cells were transfected with KLF5-siRNA or control SEAP-siRNA and induced to differentiate using the conventional hormonal stimuli. Expression of KLF5
and adipogenic transcription factors was analyzed by real-time PCR. The expression level of each gene was normalized to the level of 18s. Those normalized expression
levels were then further normalized with respect to the levels in SEAP-siRNA-transfected cells harvested on day 0. In these experiments, 3T3-L1 cells were induced to
differentiate under a suboptimal condition, which resulted in lower levels of induction of KLF5 and C/EBP mRNA expression (see Supplemental Experimental Procedures).30 CELL METABOLISM : JANUARY 2005
KLF5 in adipogenesisdifferentiation, we knocked down KLF5 expression using a MEFs on day 0 (Figure 4C and Supplemental Figure S4). The
D) Expression of KLF5 protein in cells on day 2 was analyzed by Western blotting using a monoclonal anti-KLF5 antibody (KM1785); asterisk indicates nonspecific
protein bands.
E and F) Spontaneous adipocyte differentiation in KLF5-expressing cells. Micrographs of 3T3-L1 cells infected with empty or KLF5-harboring retroviral vector and then
after reaching confluence cultured in medium without hormonal stimuli (E). Expression of KLF5, PPARγ2, and C/EBPs was analyzed by RT-PCR (F). Arrowheads, target
genes; asterisks, 18s rRNA.PPARγ2 and C/EBPα; the former was first detected 12 hr after
the induction of differentiation, while the latter was first de-
tected after 24 hr. As previously reported, expression of both
PPARγ2 and C/EBPα persisted through maturation of 3T3-L1
cells (Rosen, 2002). Although undetectable in unstimulated
3T3-L1 cells, KLF5 protein was first detected about 4 hr after
the onset of hormonal stimulation (Figure 2B); its level peaked
after 24 hr and then gradually declined. A higher molecular
weight band was also detected in the Western analysis (Figure
2B, asterisk), but this band appears to represent a protein unre-
lated to KLF5 (see further discussion in Supplemental Experi-
mental Procedures). Taken together, these findings indicate
that KLF5 expression was induced in an early stage of 3T3-L1
adipocyte differentiation, following expression of C/EBPβ/δ,
but preceding expression of PPARγ2 and C/EBPα.
KLF5 is required for adipocyte differentiation
from 3T3-L1 cells
The pattern of KLF5 expression in 3T3-L1 cells suggested its
involvement in adipocyte differentiation. To more directly ad-
dress the function of KLF5, we next examined the effect of
inhibiting it. To do this, we generated a dominant-negative form
of KLF5 (DN-KLF5) by fusing the inhibitory domain of Engrailed
with a KLF5 sequence that lacked the transactivation domain.
The resultant construct inhibited the activation of the PDGF-A
promoter (Supplemental Figure S3B), which we previously
showed to be controlled by KLF5 (Aizawa et al., 2004). When
3T3-L1 cells were infected with retroviruses harboring either
wild-type KLF5 or DN-KLF5 and then hormonally stimulated to
differentiate, Oil-Red-O staining on day 8 after induction
showed that constitutive overexpression of DN-KLF5 almost
completely blocked the accumulation of lipid droplets (Figure
3A). Conversely, forced expression of wild-type KLF5 resulted
in accumulation of lipid droplets in a larger fraction of cells than
was seen with infection of the empty control retrovirus. In addi-
tion, expression of PPARγ2 and C/EBPα was markedly reduced
in DN-KLF5-expressing cells (Figure 3B), although expression
of C/EBPβ was not. On day 0, the expression of C/EBPδ was
weaker in DN-KLF5-expressing cells than in control cells (Fig-
ure 3B), but during differentiation levels of C/EBPδ expression
were comparable in the two cells groups. This suggests KLF5
acts downstream of C/EBPβ/δ but upstream of PPARγ2 and
C/EBPα. Notably, KLF5 expression was also reduced in DN-
KLF5-expressing cells. The mechanism for this reduction is not
immediately clear. One possibility is autoregulation, though
KLF5 did not transactivate the KLF5 promoter in reporter
analyses, nor did it bind to the endogenous promoter in chro-
matin immunoprecipitation assays (data not shown). It is there-
fore unlikely that KLF5 is controlled directly by its protein. In
any case, the reduction in expression of KLF5 may also con-
tribute to the overall effects of DN-KLF5 in 3T3-L1 cells.
To further confirm the role played by KLF5 in 3T3-L1 cellCELL METABOLISM : JANUARY 2005specific siRNA (Aizawa et al., 2004). Cells transfected with
KLF5-siRNA showed significantly less expression of KLF5,
PPARγ, and C/EBPα (Figure 3C) than cells transfected with
control SEAP-siRNA. By contrast, the expression of C/EBPβ
and δ was not significantly altered in KLF5-siRNA transfected
cells. As expected, the level of KLF5 protein was reduced by
KLF5-siRNA on day 2 (Figure 3D).
It was also particularly noteworthy to us that when confluent
cultures of cells overexpressing KLF5 were maintained in me-
dium containing 10% calf serum (CS) but no hormonal stimuli
for 10 days, approximately half of the cells underwent sponta-
neous adipocyte differentiation (Figure 3E), accompanied by
expression of C/EBPα and PPARγ2 (Figure 3F). In sharp con-
trast, cells infected with the empty retrovirus showed no sign
of lipid accumulation or expression of C/EBPα and PPARγ2
(Figures 3E and 3F). Despite clear accumulation of lipid drop-
lets in KLF5-expressing cells, expression of C/EBPβ/δ was not
significantly increased (Figure 3F). When the level of C/EBPβ/δ
expression was analyzed using real-time PCR, expression of
these genes was found to be comparable in KLF5-overexpress-
ing and control cells (data not shown). It thus appears KLF5 is
able to directly affect expression of PPARγ2 and C/EBPα, even in
the absence of hormonal stimulation, and is indispensable to
the adipocyte differentiation program in 3T3-L1 cells.
We next tested whether overexpression of KLF5 might in-
duce adipogenesis in NIH-3T3 fibroblasts (Yeh et al., 1995).
Retroviral overexpression resulted in an approximately 2-fold
increase in the level of KLF5 mRNA and protein on day 0. When
cells were induced to differentiate, KLF5-expressing cells ex-
pressed a significantly higher level of PPARγ on day 3 than
control cells infected with empty retrovirus (data not shown).
However, we did not find significant differences in the expres-
sion levels of adipocyte markers on day 10, and very few
(w1%) cells contained small lipid droplets (data not shown),
suggesting that the level of KLF5 overexpression in these ex-
periments is not sufficient to induce adipocyte differentiation in
NIH-3T3 cells. Additional studies will be needed to clarify the
effects of KLF5 on adipocyte differentiation programs in NIH-
3T3 cells.
KLF5+/− embryonic fibroblasts exhibit severely impaired
adipocyte differentiation
To further analyze the importance of KLF5 in adipocyte differ-
entiation, primary mouse embryonic fibroblasts (MEFs) were
prepared from wild-type and KLF5+/− embryos collected on
ED13.5 and then subjected to hormone-induced adipocyte dif-
ferentiation. By day 10 after induction, less than 20% of KLF5+/−
MEFs bore lipid droplets, whereas 50%–60% of wild-type
MEFs did so (Figure 4A), and, as expected, the level of KLF5
protein was reduced in KLF5+/− MEFs (Figure 4B). Real-time
PCR analysis showed that the level of KLF5 expression in
KLF5+/− MEFs was approximately 58% of that in wild-type31
A R T I C L EFigure 4. Impaired adipocyte differentiation in KLF5+/− embryonic fibroblasts
Embryonic fibroblasts prepared from wild-type (wt) and KLF5+/− embryos were
induced to differentiate.
A) Cells were staining with Oil-Red-O on day 8.
B) Immunoblot analysis of KLF5 protein expression in MEFs. Cells were har-
vested 48 hr after the induction for differentiation. Arrowheads indicate the posi-
tions of bands corresponding to KLF5 protein; asterisks indicate nonspecific pro-
tein bands.
C) Expression of KLF5 and adipogenic transcription factors was analyzed by
semiquantitative RT-PCR. Arrowheads, target genes; asterisks, 18s rRNA. Note
that during differentiation experiments the patterns of gene expression in MEFs
differed from those in 3T3-L1 cells (compare Supplemental Figures S2 and S4).levels of C/EBPα and PPARγ2 expression were also signifi-
cantly lower in KLF5+/− cells than in wild-type cells (62.9% and
40.8% on day 10, respectively), which further confirmed that
KLF5 lies upstream of PPARγ2 and/or C/EBPα. By contrast, the
levels of C/EBPβ were comparable in KLF5+/− and wild-type
cells (Figure 4C and Supplemental Figure S4), and the level of
C/EBPδ was somewhat higher in KLF5+/− cells. Apparently,
their expression does not require proper expression of KLF5,
at least during differentiation of 3T3-L1 cells and MEFs.
Because KLF5−/− embryos die before ED8.5 (Shindo et al.,
2002), we were unable to obtain KLF5−/− MEFs. Nevertheless,
the defective adipocyte differentiation of KLF5+/− MEFs clearly
demonstrates the importance of appropriate KLF5 expression
in adipocyte differentiation.32KLF5 acts in concert with C/EBPβ and δ to directly
control PPARγ2 promoter activity
Because the results so far suggest that KLF5 induces PPARγ2
expression, we examined whether KLF5 might be directly in-
volved in the control of PPARγ2 transcription. A 0.6 kb proximal
promoter region of PPARγ2 was previously shown to be suffi-
cient to drive the gene’s expression in reporter assays (Clarke
et al., 1997). We found that, by itself, KLF5 stimulated modest
PPARγ2 promoter activity in reporter assays (Figure 5A, 2.7-
fold over control). On the other hand, when KLF5 was cotrans-
fected with C/EBPβ, or especially C/EBPδ, the two acted in
concert to more strongly transactivate the promoter (Figure
5A). The activation was synergistic and dependent on the pres-
ence of C/EBP binding sites, which were identified in earlier
studies (Clarke et al., 1997). Mutation of the tandem C/EBP
binding sites located at bps −340 and −327 in the PPARγ2 pro-
moter abolished the activation (Figure 5A, compare lanes 5 ver-
sus 8 and 6 versus 9).
Sequence analysis of the PPARγ2 promoter identified a pos-
sible KLF5 binding element at −278 bp. To test whether KLF5
would bind to this element in vitro, we carried out electropho-
retic mobility shift assays (EMSAs) using in vitro translated
Flag-tagged KLF5. We found that KLF5 did indeed bind an oli-
gonucleotide probe corresponding to the element (Figure 5B).
That this element is important for KLF5-mediated activation
was then confirmed by the finding that its mutation within the
PPARγ2 promoter-luciferase construct (pGL3-PPARγ2 mutKLF)
significantly attenuated the ability of KLF5 to transactivate the
PPARγ2 promoter (Figure 5A, lane 4 versus 10). The mutation
also attenuated the synergistic activation of PPARγ2 promoter
by KLF5 and C/EBPβ/δ (Figure 5A, lanes 5 versus 11 and 6
versus 12). Thus, the binding of KLF5 and C/EBPβ/δ to their
respective binding sites located within an 80 bp region (−340 to
−260 bp) of the PPARγ2 promoter was required for synergistic
activation of PPARγ2 promoter.
With those results in mind, we hypothesized that KLF5 might
directly interact with C/EBP, which we tested using two-hybrid
assays. After fusing the VP16 activation domain (AD) to full-length
KLF5 and the Gal4 DNA binding domain (DBD) to C/EBPβ or
C/EBPδ, cotransfection of VP16AD-KLF5 with either Gal4DBD-
C/EBPβ or Gal4DBD-C/EBPδ resulted in clear activation of re-
porter activity (Figure 5C), indicating that KLF5 and C/EBPβ/δ
do physically interact in this assay system.
To further analyze the physical interaction between KLF5 and
C/EBPβ/δ, we also carried out a set of coimmunoprecipitation
experiments. As shown in Figure 5D, when flag-tagged KLF5
(Fl-KLF5) and C/EBPβ or δ were overexpressed in HeLa cells,
C/EBPβ/δ were detected in the precipitants pulled down with
anti-flag antibody (Figure 5D, a and b), whereas C/EBPβ/δ were
almost undetectable in precipitates from control cells, indicat-
ing C/EBPβ/δ specifically bound to Fl-KLF5. Conversely, when
cell lysates containing KLF5 and C/EBPβ or δ were immuno-
precipitated using anti-C/EBPβ/δ antibodies, KLF5 was de-
tected in the precipitates (Figure 5D, c and d). Along with the
data from mammalian two-hybrid assays, these findings de-
monstrate that KLF5 and C/EBPβ/δ can physically interact with
one another in cells.
C/EBPβ/δ induces KLF5 expression during adipogenesis
Because KLF5 expression followed induction of C/EBPβ/δ (Fig-
ure 2A), and manipulation of KLF5 activity did not significantlyCELL METABOLISM : JANUARY 2005
KLF5 in adipogenesisaffect expression of C/EBPβ/δ (Figures 3 and 4), we hypothe-
sized that C/EBPβ and/or C/EBPδ lies upstream of KLF5. To
test this hypothesis, we first examined whether C/EBPβ/δ di-
rectly controls KLF5 promoter activity. We found that overex-
pression of either C/EBPβ or δ resulted in activation of the
KLF5 promoter (from −751 to +232) in reporter analyses (Figure
6A). Moreover, sequence analysis of the KLF5 5#-flanking re-
gion revealed a well-conserved C/EBP binding motif located at
−411 bp. That this potential C/EBP element is important for
C/EBP-mediated activation of KLF5 was confirmed by the find-
ing that mutating the element within the KLF5 promoter-lucifer-
ase construct (pGL3-KLF5 mutC/EBP) attenuated the activa-
tion of the KLF5 promoter by C/EBPβ/δ (Figure 6A). In addition,
EMSAs showed that C/EBPβ and δ were both capable of
specifically binding to the element in vitro (Figure 6B), and that
formation of shift complexes was competitively inhibited by the
presence of cold self probes, but not by mutant oligonucleo-
tides (Figure 6B, lanes 2, 3, 6, and 7). Finally, these DNA-pro-
tein complexes were supershifted in the presence of corre-
sponding antibodies (Figure 6B, lanes 4 and 8).
To assess the role of C/EBPs in the induction of endogenous
KLF5 during adipocyte differentiation, we utilized MEFs derived
from C/EBPβ+/− · C/EBPδ+/−, C/EBPβ−/− · C/EBPδ+/−, and
C/EBPβ+/− · C/EBPδ−/− mice (Tanaka et al., 1997). As compared
with MEFs from C/EBPβ+/− · C/EBPδ+/− mice, the C/EBPβ−/− ·
C/EBPδ+/− and C/EBPβ+/− · C/EBPδ−/− MEFs exhibited im-
paired adipocyte differentiation, (Figure 6C and Tanaka et al.,
1997) which was accompanied by low levels of PPARγ2 and
C/EBPα expression (Figure 6D). Levels of KLF5 expression
were also significantly reduced during differentiation in both
C/EBPβ−/− · C/EBPδ+/− and C/EBPβ+/− · C/EBPδ+/− MEFs (Fig-
ure 6D), though an even more pronounced reduction was seen
in C/EBPβ+/− · C/EBPδ−/− MEFs. The levels of KLF5 expression
were 50.9% in C/EBPβ+/− · C/EBPδ−/− and 75.5% in C/EBPβ−/− ·
C/EBPδ+/− MEFs of that seen in C/EBPβ+/− · C/EBPδ+/− cells
on day 10. Since both C/EBPβ and C/EBPδ were capable of
transactivating the KLF5 promoter in reporter assays, the loss
of either factor’s function might be compensated by the other.
Nevertheless, these data clearly demonstrate that C/EBPβ/δ
are required for expression of KLF5 in MEFs.
KLF5 binds to the endogenous PPARγ2 promoter
in intact chromatin
It is now well known that transcriptional regulation within intact
chromatin can be quite different from that observed using in
vitro binding and reporter assays. For that reason, we next ana-
lyzed the binding of KLF5 and C/EBPs to their endogenous
target genes in intact cells using chromatin immunoprecipita-
tion (ChIP) assays. Chromatin samples were prepared from
3T3-L1 cells after induction of adipocyte differentiation, and
then immunoprecipitated with specific antibodies against
C/EBPα, C/EBPβ, C/EBPδ, or KLF5. No binding of these
factors to the PPARγ2 promoter was observed on day 0. By
day 2.5, however, both C/EBPβ and δ bound to a region within
the PPARγ2 promoter that contained the C/EBP elements (Fig-
ure 7A, lanes 4 and 5), while KLF5 bound a region containing
the KLF5 binding site (Figure 7C, lane 3); there was no binding
in the region of −2000 bp, which does not contain C/EBP (Fig-
ure 7B) or KLF (Figure 7D) binding motifs. By day 10, the bind-
ing of C/EBPδ was undetectable, and C/EBPβ binding was
much weaker than on day 2.5 (Figure 7A, lanes 4 and 5). How-CELL METABOLISM : JANUARY 2005ever, the binding of C/EBPα was now detectable (Figure 7A,
lane 3), indicating that C/EBPα becomes the major C/EBP pro-
tein binding to the PPARγ2 promoter in mature 3T3-L1 adipo-
cytes, which is consistent with the current model of PPARγ2
control by C/EBPs. KLF5 binding to the PPARγ2 promoter
was detectable on day 10, but was much reduced (Figure 7C,
lane 3).
ChIP analyses also demonstrated that C/EBPβ/δ bound the
KLF5 promoter in intact chromatin. Again, no binding was seen
on day 0 (Figure 7E, lanes 3–5), but by day 2.5, the binding of
C/EBPβ/δ to the region of the KLF5 promoter containing the
C/EBP element was apparent (Figure 7E), and no binding was
detected in the region of −2000 bp, which contains no C/EBP
motifs (Figure 7F). By day 10, C/EBP binding was no longer de-
tected.
Discussion
Earlier studies established that differentiation of the 3T3-L1
preadipocyte cell line into adipocytes requires sequential acti-
vation of various transcription factors, including C/EBPs and
PPARγ2. The results of the present study demonstrate that
KLF5 mediates between the early factors, C/EBPβ/δ, and the
late factor, PPARγ2, and that KLF5 is required for adipocyte
differentiation. Thus, the present study establishes KLF5 as a
key component of the transcription factor network controlling
adipogenesis.
One of the most distinctive phenotypes caused by haploin-
sufficiency of KLF5 in mouse was the impairment of WAT de-
velopment during the neonatal period (Figure 1 and Supple-
mental Figure S1). Our findings clearly showed that even a
50% reduction in the level of KLF5 is sufficient to impair adipo-
cyte differentiation, which is indicative of the importance of
precise regulation of this transcription factor during WAT de-
velopment. The importance of precise control of KLF5 expres-
sion was also evident in analyses using culture cells. MEFs
prepared from KLF5+/− embryos exhibited much less capacity
for hormone-induced adipocyte differentiation than MEFs pre-
pared from wild-type embryos (Figure 4A). Notably, although
expression of PPARγ2 was significantly attenuated in KLF5+/−
MEFs, expression of C/EBPβ/δ was not: even when C/EBPβ/δ
were properly expressed, reduced expression of KLF5 resulted
in failure of the differentiation to progress. Likewise expression
of PPARγ2 was significantly reduced in WAT from KLF5+/− mice
on day 3 after birth, despite no changes in the levels of
C/EBPβ/δ expression. The importance of the stoichiometry of
KLF5 and C/EBPβ/δ in execution of the differentiation program
was also apparent from reporter assays in which KLF5 and
C/EBPβ/δ acted synergistically to control PPARγ2 promoter ac-
tivity (Figure 5A). All these observations demonstrate that KLF5
is required for adipocyte differentiation, and that the expression
level of KLF5 greatly affects the differentiation processes.
Our ChIP experiments showed that C/EBPβ, C/EBPδ and
KLF5 were all bound to the endogenous PPARγ2 promoter in
intact chromatin on day 2 during differentiation (Figure 7), but
that by day 10 only C/EBPα was bound, indicating that the
transcription factors binding to the PPARγ2 promoter during the
early induction stage of differentiation differ from those binding
during the late maintenance stage. Moreover, the simultaneous
binding of KLF5 and C/EBPβ/δ to the endogenous PPARγ2 pro-
moter (Figure 7), the synergistic activation of the PPARγ pro-2
33
A R T I C L EFigure 5. KLF5 acts in concert with C/EBP to transactivate the PPARγ2 promoter
A) 3T3-L1 cells were transfected with pGL3-PPARγ2, a luciferase reporter construct under the control of the PPARγ2 promoter (−378 to +52 bp), or with reporter
constructs containing mutations within the potential C/EBP and KLF binding sites. Results are shown as fold activation over the activity of pGL3-PPARγ2 cotransfected
with empty expression plasmid. Error bars indicate SEM.
B) EMSA of the KLF5 binding site (−278 to −260 bp) within the PPARγ2 promoter. Radiolabeled DNA probes were incubated with in vitro-translated flag-tagged KLF5
(Fl-KLF5). Cold competitors of the wild-type or mutated sequence were added to the reactions in lanes 2–5. Addition of anti-flag antibody (Fl) to the reaction resulted
in formation of the supershift (SS) complex in lane 6.
C) Two-hybrid analysis of interactions between KLF5 and C/EBP. An expression vector in which the VP16 AD was fused to KLF5 was cotransfected with a reporter
plasmid (pG5-luc) and expression vectors containing the Gal4 DBD fused to C/EBPβ/δ into NIH-3T3 cells. Results are shown as fold activation over the activity of
pGL5-luc with empty control plasmid. Error bars, SEM.34 CELL METABOLISM : JANUARY 2005
KLF5 in adipogenesisturn controls PPARγ2 expression, thus mediating both the earlyare lineage-determined preadipocytes. The reduced adipocyte
D) Coimmunoprecipitation of C/EBPβ/δ with KLF5. (a) and (b) Lysates from HeLa cells overexpressing C/EBPβ (a) or C/EBPδ (b) and Flag-tagged KLF5 (Fl-KLF5) or
empty control vector were immunoprecipitated with anti-flag antibody, after which the immunoprecipitates were subjected to immunoblot analyses for the presence of
C/EBPβ/δ. As previously reported, three isoforms of C/EBPβ (36, 34, and 20 kDa) were generated from the C/EBPβ expression vector by alternate use of three
translation initiation sites (Input). (c) and (d) Lysates from HeLa cells expressing KLF5 and C/EBPβ (c) or C/EBPδ (d) were immunoprecipitated with anti-C/EBPβ or δ
antibody or control rabbit IgG. Immunoprecipitates were subjected to immunoblot analysis using monoclonal KLF5 antibody (KM1785).moter by these factors (Figure 5A), and their direct interaction
in two-hybrid analyses and coimmunoprecipitation experi-
ments (Figures 5C and 5D) suggest that these molecules may
form enhanceosomes (Merika and Thanos, 2001) on the
PPARγ2 promoter. The time-dependent changes in the factors
binding to the PPARγ2 promoter further suggests that different
enhanceosomes are formed at different stages of differentia-
tion, and that the PPARγ2 promoter responds to different infor-
mation during adipocyte differentiation and in mature adipo-
cytes (Tsytsykova and Goldfeld, 2002). This multiplicity in the
PPARγ2 regulatory program is consistent with earlier studies
showing that PPARγ and C/EBPα could be induced in vivo in
C/EBPβ/δ double-knockout mice, which suggests the exis-
tence of alternative, C/EBPβ/δ-independent pathways leading
to the expression of PPARγ and C/EBPα. It is also interesting
that BAT development was not disturbed in KLF5+/− mice, and
that PPARγ2 expression was not diminished in KLF5+/− BAT
(data not shown). It is therefore likely that particular enhanceo-
somes are formed on the PPARγ2 promoter in a context-depen-
dent manner (e.g., WAT versus BAT, immature versus mature
adipocytes), enabling PPARγ2 to respond differentially to a vari-
ety of stimuli. In that regard, it will be important to further ana-
lyze the control of KLF5 expression and activity in adipocytes,
as KLF5 almost certainly transduces different information than
C/EBPβ/δ. For instance, KLF5 expression is controlled by
Egr-1 in smooth muscle cells, while KLF5 protein can interact
with a variety of factors, including RARα (Shindo et al., 2002),
NF-κB (Aizawa et al., 2004), p300 (Miyamoto et al., 2003), CBP
(Zhang and Teng, 2003), and can be controlled posttranslation-
ally by phosphorylation (Zhang and Teng, 2003).
Although neonatal KLF5+/− mice exhibited clear WAT hypot-
rophy, which was characterized by a reduction in adipocyte
size but not number, WAT mass increased during the first sev-
eral weeks in these mice, so that by about 4 weeks of age WAT
masses in KLF5+/− and wild-type mice were comparable. In the
mouse, the characteristic morphology of adipocytes develops
during the first 24 hr after birth, and there is little or no lipid
accumulation at the time of birth (Ailhaud et al., 1992). After
this rapid development, however, differentiation of adipocytes
from preadipocytes is believed to continue throughout the life-
time of an animal (Rosen, 2002). Interestingly, numerous small
cells that lacked lipid droplets were seen in neonatal KLF5+/−
WAT (Figure 1B). The fact that these cells disappeared in older
mice suggests they may represent preadipocytes or cells still
undergoing differentiation, and that despite the reduced KLF5
levels they eventually achieve full differentiation, which would
explain the normal WAT mass seen in adult KLF5+/− mice.
Thus, reducing the level of KLF5 does not appear to perturb
lineage determination of preadipocytes, at least when 50% of
KLF5 was present. Instead, the reduced KLF5 appears to affect
the processes of differentiation of preadipocytes to adipocytes.
Consistent with this idea, expression of KLF5 was observed
early after the induction of differentiation in 3T3-L1 cells, whichCELL METABOLISM : JANUARY 2005differentiation seen in KLF5+/− MEFs is also consistent with
KLF5’s role in early adipocyte differentiation, although the pre-
sent experiments cannot distinguish KLF5’s role in preadipo-
cytes from an effect on lineage commitment. To further eluci-
date the role of KLF5 in lineage determination and early
differentiation, it will be important to examine the activity of
KLF5 in a model in which multipotent stem cells differentiate
into preadipocytes.
The present study establishes for the first time the important
role played by KLF5 in adipogenesis in vivo, although several
in vitro studies have previously implicated KLFs in the control
of adipocyte differentiation. For instance, KLF2 is known to be
expressed in unstimulated 3T3-L1 cells and to be downregu-
lated within two days after applying the hormonal stimuli (Ban-
erjee et al., 2003). Overexpression of KLF2 in 3T3-L1 cells re-
duces adipocyte differentiation, suggesting that this factor
negatively regulates adipocyte differentiation. Consistent with
that idea, KLF2 is known to bind to the sequence between
bps −82 and −93 of the PPARγ2 promoter, thereby inhibiting its
activity. Although it has been shown that KLF family members
recognize similar sequences, at least in in vitro assays (Kaczyn-
ski et al., 2003), this KLF2 binding site is located 3# of the KLF5
binding site (−278 to −266) identified in the present study and
appears not to be the site responsible for KLF5-dependent
transcriptional regulation.
KLF15, which reportedly controls transcription of GLUT4, is
another KLF that has been shown to be involved in adipocyte
differentiation. Expression of KLF15 is first detectable three
days after induction of differentiation in 3T3-L1 cells, and high
levels of KLF15 expression persist throughout adipocyte matu-
ration (Gray et al., 2002). Taken together, these findings are
indicative of the sequential expression of KLFs during adipo-
cyte differentiation: KLF2 is expressed in preadipocytes and
then rapidly downregulated upon induction of differentiation;
KLF5 is induced during the early stages of differentiation and
downregulated in mature 3T3-L1 adipocytes; and KLF15 fol-
lows expression of KLF5 and is abundantly expressed in ma-
ture adipocytes. This sequential expression of KLFs and the
similarity in the binding sequences suggest interplay among
KLFs in the control of adipocyte differentiation and function.
For instance, KLF15 expression is induced after the induction
of PPARγ2 and C/EBPα in 3T3-L1 cells (Y.O. and I.M., unpub-
lished observations). It would be interesting to know whether
KLF15 takes over the function of KLF5 in enhanceosomes
formed on the PPARγ2 promoter in mature adipocytes. In this
regard, it is worth noting that the amino-terminal regions of
KLFs are variable and contain different transcriptional activa-
tion and repression domains, as well as interaction domains
for other proteins. Indeed, the structure of the amino-terminal
of KLF5 is quite different from that of KLF15. Thus, if KLF15
replaces KLF5 on the PPARγ2, the resultant enhanceosome
could acquire different interacting proteins and functions.
In summary, the present study provides compelling new evi-
dence of the pivotal role played by KLF5 in adipocyte differenti-
ation in vivo and in vitro. KLF5 is induced by C/EBPβ/δ and in35
A R T I C L EFigure 6. C/EBPβ/δ directly controls the KLF5 promoter
A) A luciferase reporter construct under the control of the 0.7 kb KLF5 promoter fragment (−751 to +232 bp) or a construct containing a mutation within the C/EBP
element were cotransfected into 3T3-L1 cells with empty vector (pCAG-MS), pCAG-C/EBPβ or pCAG-C/EBPδ. Results are expressed as fold activation over the activity
of pGL3-KLF5 cotransfected with empty vector. Error bars, SEM.
B) EMSA of C/EBPβ/δ binding to the sequence between −420 and −392 bp of the human KLF5 5#-flanking sequence. Radiolabeled probes were incubated with
in vitro translated C/EBPβ or δ protein. In lanes 3 and 7, an excess of cold self competitor was added. In lanes 2 and 6, an excess of cold mutant oligonucleotide was
added. In lanes 4 and 8, anti-C/EBPβ and anti-C/EBPδ antibodies were added, respectively. The free probes ran off the gel. SS, supershifted complexes; asterisks,
nonspecific shift bands.
C) Analysis of adipocyte differentiation of MEFs prepared from C/EBPβ/δ knockout mouse embryos. Lipid droplets were stained on day 8.
D) Real-time PCR analysis of gene expression in MEFs from C/EBP knockout mice. Expression levels of each gene were normalized to the levels of 18s. That
normalized expression was then further normalized with respect to the level in C/EBPβ+/− · C/EBPδ+/− cells on day 0.36 CELL METABOLISM : JANUARY 2005
KLF5 in adipogenesisFigure 7. ChIP analysis of KLF5 and C/EBP binding
to target genes in chromatin
Intact 3T3-L1 cells were fixed in formaldehyde on
the indicated days during differentiation, after which
chromatin samples were subjected to ChIP analysis.
A) C/EBP binding to the region containing C/EBP
elements within the PPARγ2 promoter (−437 to −232
bp). The immunoprecipitated region was PCR am-
plified using specific primers.
B) C/EBP binding to the region of −2000 bp of the
PPARγ2 promoter, which contains neither C/EBP nor
KLF binding motifs.
C) KLF5 binding to the region containing the KLF
binding element within the PPARγ2 promoter (−437
to −232 bp).
D) KLF5 binding to the region of −2000 bp.
E) C/EBP binding to its binding region within the
KLF5 promoter (−537 to −333 bp).
F) C/EBP binding to the region of −2000 bp.
G) Schematic representations of positions of the
transcription factor binding sites and PCR primers.and late stages of the differentiation program. The results also
suggest that KLF5 may form an enhanceosome with C/EBPβ/δ
on the PPARγ2 promoter. Future studies of the molecular func-
tion of KLF5 should provide additional insight into adipocyte
differentiation programs in which divergent environmental cues
and intracellular signals are processed by multiple protein-
DNA complexes.
Experimental procedures
Cell culture, in vitro differentiation
Methods for culture and induction of differentiation of 3T3-L1, MEFs, and
NIH-3T3 are described previously (Ntambi et al., 1988; Tanaka et al., 1997;
Yeh et al., 1995).CELL METABOLISM : JANUARY 2005Western blot analysis
The monoclonal KLF5 antibody (KM1785) (Shindo et al., 2002) recognized
two major bands in mouse cell culture samples. The 60 kDa band repre-
sents KLF5 protein (Supplemental Figure S5A). The higher MW band is very
likely a protein (proteins) unrelated to KLF5 (see further discussion in Sup-
plemental Experimental Procedures).
Plasmids and luciferase assays
cDNAs for KLF5 (kindly provided by Dr. C.T. Teng), C/EBPα, C/EBPβ, and
C/EBPδ (kindly provided by Dr. S. McKnight) were inserted into pCAGMS
(Shindo et al., 2002). The Engrailed repression sequence (kindly provided
by Dr. S.Y. Sokol) was fused with KLF5 cDNA to generate pCAG-DN-KLF5.
The human KLF5 promoter (−751 to +232) (Kawai-Kowase et al., 1999) and
mouse PPARγ2 promoter (−378 to +52 bp) were subcloned into the pGL3-
basic (Promega). The cis-elements mutant constructs were generated by37
A R T I C L EPCR. NIH-3T3 and 3T3-L1 cells were transfected when the cells reached
60%–80% confluency. The luciferase activity was normalized to the protein
concentration of each cell lysate (Manabe and Owens, 2001a).
Retroviral infection
Full-length KLF5 and DN-KLF5 sequences were subcloned into pMXs (Kita-
mura et al., 2003). 3T3-L1 cells were infected with retrovirus particles, and
subsequently the cells were maintained in the medium containing puromy-
cin for one week to select bulk cell populations stably transformed with
the viruses.
Small interfering RNA (siRNA)
siRNAs were constructed using the Silencer siRNA Construction kit (Am-
bion). Eight g of siRNA was transfected into 3T3-L1 cells using Lipofec-
tamine 2000 (Invitrogen). After incubating the cells for 18 hr, conventional
hormonal stimuli were started.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
and real-time PCR
Semiquantitative multiplex PCR was carried out as previously described
(Manabe and Owens, 2001b). Quantitative real-time PCR analyses were
carried out using the Taqman procedure with 36B4 or 18s as an internal
control.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were carried out essentially as described previously (Manabe and
Owens, 2001a). KLF5 and C/EBPβ/δ proteins were synthesized using a TNT
reticulocyte lysate system (Promega). To obtain better separation of shifted
bands, gels were electrophoresed until most free probes had run off the
gels.
Coimmunoprecipitation assays
HeLa cells were first transiently cotransfected with 3 g of either pCAG-
C/EBPβ or pCAG-CEBPδ and 3 g of either pCAG-Fl-KLF5 or empty
pCAGMS. Coimmunoprecipitation assays were then carried out as pre-
viously described.
Chromatin immunoprecipitation (ChIP) assays
ChIP assays were carried out as previously described using a rabbit poly-
clonal anti-KLF5 antibody (Manabe and Owens, 2001a, 2001b). The speci-
ficity of this antibody was analyzed by Western blotting (Supplemental Fig-
ure S5B).
Supplemental data
Supplemental data include five figures and Supplemental Experimental Pro-
cedures and can be found with this article online at http://www.cellmetabolism.
org/cgi/content/1/1/27/DC1/.
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